Initiation, adherence to AIs low for older women with DCIS

By A Mystery Man Writer

(HealthDay)—For older women with estrogen receptor (ER)-positive ductal carcinoma in situ (DCIS), initiation of aromatase inhibitors (AIs) and adherence to treatment are low, according to a study published online Oct. 25 in Cancer.

Impact of Endocrine Therapy Adherence on Outcomes in Elderly Women with Early-Stage Breast Cancer Undergoing Lumpectomy Without Radiotherapy

Cancers, Free Full-Text

Frontiers Neuro-immune-endocrine mechanisms with poor adherence to aromatase inhibitor therapy in breast cancer

Cancers, Free Full-Text

PDF) Identifying determinants of adherence to adjuvant endocrine therapy following breast cancer: A systematic review of reviews

Arthralgia in Breast Cancer Survivors: An Integrative Review of Endocrine Therapy

PDF) Factors associated with initiation and continuation of endocrine therapy in women with hormone receptor-positive breast cancer

Current Oncology, Free Full-Text

Breast Cancer in Older Women

©2016-2024, reintegratieinactie.nl, Inc. or its affiliates